Elevance Health, Inc. financial data

Symbol
ELV on NYSE
Location
Indianapolis, IN
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 21 Oct 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 147% % 1.6%
Debt-to-equity 180% % 5.3%
Return On Equity 13% % -17%
Return On Assets 4.6% % -19%
Operating Margin 3.9% % -20%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 222,238,763 shares -4.2%
Common Stock, Shares, Outstanding 222,036,187 shares -4.3%
Entity Public Float $116,687,067,115 USD 12%
Common Stock, Value, Issued $2,000,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 223,300,000 shares -3.7%
Weighted Average Number of Shares Outstanding, Diluted 223,700,000 shares -4%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $194,820,000,000 USD 12%
Operating Income (Loss) $7,563,000,000 USD -11%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $7,101,000,000 USD -14%
Income Tax Expense (Benefit) $1,573,000,000 USD -18%
Net Income (Loss) Attributable to Parent $5,533,000,000 USD -14%
Earnings Per Share, Basic 24 USD/shares -11%
Earnings Per Share, Diluted 24 USD/shares -11%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $8,713,000,000 USD 11%
Other Assets, Current $5,213,000,000 USD -12%
Assets, Current $63,778,000,000 USD 1.5%
Other Long-term Investments $10,648,000,000 USD 13%
Property, Plant and Equipment, Net $4,657,000,000 USD 3.4%
Operating Lease, Right-of-Use Asset $567,000,000 USD -2.9%
Intangible Assets, Net (Excluding Goodwill) $11,327,000,000 USD 9.7%
Goodwill $28,451,000,000 USD 9.6%
Other Assets, Noncurrent $2,777,000,000 USD 6.7%
Assets $122,749,000,000 USD 5.3%
Liabilities, Current $40,878,000,000 USD -2.7%
Deferred Income Tax Liabilities, Net $2,315,000,000 USD 11%
Operating Lease, Liability, Noncurrent $658,000,000 USD -3.9%
Other Liabilities, Noncurrent $4,137,000,000 USD 15%
Liabilities $78,667,000,000 USD 8.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax $543,000,000 USD -11%
Retained Earnings (Accumulated Deficit) $35,586,000,000 USD 1.2%
Stockholders' Equity Attributable to Parent $43,953,000,000 USD 0.41%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $44,082,000,000 USD 0.46%
Liabilities and Equity $122,749,000,000 USD 5.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,017,000,000 USD -49%
Net Cash Provided by (Used in) Financing Activities $1,909,000,000 USD -6066%
Net Cash Provided by (Used in) Investing Activities $103,000,000 USD
Common Stock, Shares Authorized 900,000,000 shares 0%
Common Stock, Shares, Issued 222,036,187 shares -4.3%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $788,000,000 USD -163%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $8,713,000,000 USD 11%
Deferred Tax Assets, Valuation Allowance $294,000,000 USD 8.5%
Deferred Tax Assets, Gross $2,411,000,000 USD 12%
Operating Lease, Liability $811,000,000 USD -4.5%
Payments to Acquire Property, Plant, and Equipment $196,000,000 USD -30%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $5,479,000,000 USD -35%
Lessee, Operating Lease, Liability, to be Paid $886,000,000 USD -7.3%
Property, Plant and Equipment, Gross $8,329,000,000 USD 5.4%
Operating Lease, Liability, Current $153,000,000 USD -6.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two $154,000,000 USD -7.8%
Lessee, Operating Lease, Liability, to be Paid, Year One $184,000,000 USD -5.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) $174,000,000 USD -228%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $75,000,000 USD -30%
Lessee, Operating Lease, Liability, to be Paid, Year Three $127,000,000 USD -4.5%
Deferred Tax Assets, Operating Loss Carryforwards $428,000,000 USD 16%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100,000,000 shares 0%
Unrecognized Tax Benefits $775,000,000 USD 66%
Lessee, Operating Lease, Liability, to be Paid, Year Four $112,000,000 USD 6.7%
Additional Paid in Capital $8,908,000,000 USD -2.2%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $644,000,000 USD 4.4%
Depreciation, Depletion and Amortization $231,000,000 USD 5%
Deferred Tax Assets, Net of Valuation Allowance $2,117,000,000 USD 12%
Interest Expense $1,104,000,000 USD 10%